110 related articles for article (PubMed ID: 11730721)
1. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2.
Yamaguchi H; Yano I; Saito H; Inui K
Eur J Pharmacol; 2001 Nov; 431(3):297-303. PubMed ID: 11730721
[TBL] [Abstract][Full Text] [Related]
2. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
Yamaguchi H; Yano I; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
[TBL] [Abstract][Full Text] [Related]
3. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.
Ito T; Yano I; Masuda S; Hashimoto Y; Inui K
Pharm Res; 1999 Apr; 16(4):534-9. PubMed ID: 10227708
[TBL] [Abstract][Full Text] [Related]
4. Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC-PK1.
Matsuo Y; Yano I; Ito T; Hashimoto Y; Inui K
J Pharmacol Exp Ther; 1998 Nov; 287(2):672-8. PubMed ID: 9808695
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
Yamaguchi H; Yano I; Saito H; Inui K
J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
[TBL] [Abstract][Full Text] [Related]
6. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux.
Sikri V; Pal D; Jain R; Kalyani D; Mitra AK
Am J Ther; 2004; 11(6):433-42. PubMed ID: 15543082
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages.
Hirota M; Totsu T; Adachi F; Kamikawa K; Watanabe J; Kanegasaki S; Nakata K
J Infect Chemother; 2001 Mar; 7(1):16-21. PubMed ID: 11406752
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
Lowes S; Simmons NL
Br J Pharmacol; 2002 Mar; 135(5):1263-75. PubMed ID: 11877335
[TBL] [Abstract][Full Text] [Related]
9. Transport of levofloxacin in the OK kidney epithelial cell line: interaction with p-aminohippurate transport.
Matsuo Y; Yano I; Habu Y; Katsura T; Hashimoto Y; Inui K
Pharm Res; 2001 May; 18(5):573-8. PubMed ID: 11465410
[TBL] [Abstract][Full Text] [Related]
10. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
11. Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1.
Hara T; Takemura H; Kanemitsu K; Yamamoto H; Shimada J
J Infect Chemother; 2000 Sep; 6(3):162-7. PubMed ID: 11810558
[TBL] [Abstract][Full Text] [Related]
12. Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.
Yamaguchi H; Yano I; Saito H; Inui K
Pharm Res; 2004 Feb; 21(2):330-8. PubMed ID: 15032316
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
Shakibaei M; Baumann-Wilschke I; Rücker M; Stahlmann R
Arch Toxicol; 2002 Jan; 75(11-12):725-33. PubMed ID: 11876506
[TBL] [Abstract][Full Text] [Related]
14. Temperature-dependent specific transport of levofloxacin in human intestinal epithelial LS180 cells.
Fukumori S; Masago M; Ishida K; Kayano Y; Taguchi M; Hashimoto Y
Biopharm Drug Dispos; 2009 Nov; 30(8):448-56. PubMed ID: 19725017
[TBL] [Abstract][Full Text] [Related]
15. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
Bourdet DL; Thakker DR
Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
[TBL] [Abstract][Full Text] [Related]
16. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
[TBL] [Abstract][Full Text] [Related]
17. Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein.
Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
J Pharm Pharmacol; 2001 May; 53(5):699-709. PubMed ID: 11370709
[TBL] [Abstract][Full Text] [Related]
18. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.
Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
Antimicrob Agents Chemother; 2002 Feb; 46(2):344-9. PubMed ID: 11796340
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers.
Takaai M; Suzuki H; Ishida K; Tahara K; Hashimoto Y
Biol Pharm Bull; 2007 Nov; 30(11):2167-72. PubMed ID: 17978494
[TBL] [Abstract][Full Text] [Related]
20. Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophils.
Vazifeh D; Bryskier A; Labro MT
Antimicrob Agents Chemother; 1999 Feb; 43(2):246-52. PubMed ID: 9925513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
